Advertisement
Screener

Dorsey Wright & Associates Historic Quarter Change: USA Other Stocks, Sold Out

Dorsey Wright & Associates historic quarter change: USA Other Stocks, Sold out

In shares no fund filing gives a ticker for, so this site has no page for them (listed in the US), over 23 quarters from 2013-06-30 to 2026-06-30, Dorsey Wright & Associates opened 155 positions, added to 135, reduced 128 and sold out of 172.

  • Q2 2026: Stock ASCENDIS PHARMA A/S SPONSORED; Country of operation —; Class COM; Shares before 11,879.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1376772), 23 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-06); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-06); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-20); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-18); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-11); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-06); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-12); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-15); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-15); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-09); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-10-11); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-07-21); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-04-08); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-01-29); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-10-29); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-07-23); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-04-20); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-01-09); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-10-31); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-07-29); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-09); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-01-28); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-10-23). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2006-12-31. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q2 2026ASCENDIS PHARMA A/S SPONSORED
CUSIP 04351P101
COM11,8790-11,879$2,717,084$0-$2,717,0842026-08-06

Similar Firms

Firm NameCountry13F ValueHoldings
Strid Group, LLCUnited States$0.807B85
Johnson Bixby & Associates, LLCUnited States$0.806B127
Emerald Advisors, LLCUnited States$0.808B125
BRIGADE CAPITAL MANAGEMENT, LPUnited States$0.806B23
Pathway Financial Advisors LLCUnited States$0.808B136
Flaharty Asset Management, LLCUnited States$0.806B133
OARSMAN CAPITAL, INC.United States$0.806B239
Glendon Capital Management LPUnited States$0.805B25
B&D White Capital Company, LLCUnited States$0.809B74
ASHFORD CAPITAL MANAGEMENT INCUnited States$0.809B99